Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RIVASTIGMINE

Ingredient

RIVASTIGMINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ RIVASTIGMINE PATCH 10	9.5MG	PATCH	Resolved	2024-04-02	2024-05-01	224174
SANDOZ RIVASTIGMINE PATCH 10	9.5MG	PATCH	Resolved	2023-04-21	2023-06-07	190154
SANDOZ RIVASTIGMINE PATCH 5	4.6MG	PATCH	Resolved	2024-09-03	2024-12-03	236571
SANDOZ RIVASTIGMINE PATCH 5	4.6MG	PATCH	Resolved	2024-03-11	2024-04-16	221841

Previous
1
…
6
7
8

Showing 71 to 74 of 74

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
SANDOZ RIVASTIGMINE	3MG	CAPSULE	Discontinued	2024-12-10	2024-12-11	245273
SANDOZ RIVASTIGMINE	3MG	CAPSULE	Discontinued	2024-12-10	2024-12-11	245276
SANDOZ RIVASTIGMINE	4.5MG	CAPSULE	Discontinued	2024-12-10	2024-12-11	245279
SANDOZ RIVASTIGMINE	4.5MG	CAPSULE	Discontinued	2024-12-10	2024-12-11	245282
SANDOZ RIVASTIGMINE	6MG	CAPSULE	Discontinued	2024-12-10	2024-12-11	245291
SANDOZ RIVASTIGMINE	6MG	CAPSULE	Discontinued	2025-06-25	2025-06-26	261105

Showing 11 to 16 of 16